Search and filter adverse-event reports.
1,929,324 reports(782 ms)
The patient accidentally took the third capsule of Vivotif the day after the second capsule; Case reference number US-BN-2025-001609 is a spontaneous case initially received from a consumer via Communications (reference number: USBAV25-2407) on 26-Sep-2025 and…
The patient took the first capsule of Vivotif, which was left out of refrigerator; The patient took the first capsule of Vivotif, which was left out of refrigerator; The patient took the first capsule of Vivotif, which was left out of refrigerator; Case refere…
The patient took one capsule of Vivotif while it was unrefrigerated; The patient took one capsule of Vivotif while it was unrefrigerated; The patient took one capsule of Vivotif while it was unrefrigerated; Case reference number US-BN-2025-001938 is a spontane…
Patient took second dose of Vivotif, 61 days after the first dose; Nausea experienced about 4 hours after the first dose; Vomiting experienced about 4 hours after the first dose; Nausea experienced about 4 hours after the second dose; Vomiting experienced abou…
Vivotif was left out of refrigerator for several days, maximum temperature was 65°F; Vivotif was left out of refrigerator for several days, maximum temperature was 65°F; Vivotif was left out of refrigerator for several days, maximum temperature was 65°F; Case…
The patient took the Vivotif, which stayed at room temperature for about 16 hours and 30 minutes at approximately 20 degrees; The patient took the Vivotif, which stayed at room temperature for about 16 hours and 30 minutes at approximately 20 degrees; The pati…
By accident the patient took Vivotif two days in a row; Case reference number US-BN-2025-001952 is a spontaneous case initially received from pharmacist via Bavarian Nordic (reference number: CASE-001169) on 12-Dec-2025 and concerns a 27-year-old female patien…
The patient took Vivotif after temperature excursion, temperature was around 40-50°F; The patient took Vivotif after temperature excursion, temperature was around 40-50°F; The patient took Vivotif after temperature excursion, temperature was around 40-50°F; Ca…
Patient experienced mild stomach upset for a day; Patient was fatigued; Patient experienced some diarrhea on the first day of taking the Vivotif capsule; Patient experienced headache; Case reference number US-BN-2025-001970 is a spontaneous case initially rece…
The patient stored Vivotif inside a cooler bag in the back of his truck inside an insulated cooler bag at -12 F for four hours.; The patient stored Vivotif inside a cooler bag in the back of his truck inside an insulated cooler bag at -12 F for four hours.; Th…
The patient on two separate occasions left Vivotif out overnight, 14 hours, and still took the dose the next morning; The patient on two separate occasions left Vivotif out overnight, 14 hours, and still took the dose the next morning; The patient on two separ…
The patient took vaccine of Viviotif which left out of refrigeration for approximately 23 hours/The maximum temperature that the product was exposed to would have been about 70 degrees F; The patient took vaccine of Viviotif which left out of refrigeration for…
The patient took the first dose of Vivotif with food; Case reference number US-BN-2025-002023 is a spontaneous case initially received from a pharmacist via Bavarian Nordic (reference number: CASE-001395) on 30-Dec-2025 and concerns a 19-year-old male patient.…
a bit of a stomach pain; Case reference number US-BN-2026-000010 is a spontaneous case initially received from consumer via Bavarian Nordic (reference number: CASE-001336) on 22-Dec-2025 and concerns female patient of unknown age. The patient's medical histor…
Student given Men B vaccine prior to age 16
Men B vaccination given prior to age 16.
Men B vaccination given to student prior to age 16.
The patient received MCV4. The patient was scheduled for Tdap.
patient had no reaction, no symptoms; ROTATEQ was given to a patient who is 23 months old, which is older than the age in which ROTATEQ is indicated; This spontaneous report was received from a Nurse and referred to a 23-month-old patient of unknown gender. T…
Confirmed no symptomatic AE; Inbound call from nurse calling to report TE for PROQUAD that had an excursion on 20-JAN-2026. The caller reports that a dose was administered to patient on 28-JAN-2026. Confirmed no symptomatic AE. Permission to contact HCP gra…